Literature DB >> 6230157

Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth.

C J Denbow, J M Conroy, K D Elgert.   

Abstract

One-way mixed-lymphocyte reactions (MLR) were used to assess macrophage (M phi)-derived factor-mediated modulation of normal and tumor-bearing host (TBH) T-cell immune responsiveness. Normal and TBH M psi culture supernatants contained the inhibitory substance prostaglandin E (PGE) in concentrations of 10(-8) to 10(-9) M, with TBH M phi supernatant containing approximately twice the amount of PGE as its normal counterpart. Normal and TBH MLR reactivity were both suppressed by the addition of normal host M phi supernatant. However, TBH T cells were less inhibited by TBH M phi supernatant (55%) as compared to normal host T cells (73%). Although dialyzed M phi supernatants were less inhibitory (17-19%) on normal host T-cell MLR reactivity, TBH T-cell responses were enhanced (20-46%). Indomethacin or eicosatetraynoic acid treatment of M phi reduced PGE levels in the supernatants and in general enhanced MLR reactivity. When PGE1 and PGE2 were titrated in the MLR, normal host T lymphocytes were more susceptible to inhibition than were TBH. Concentrations of PGE1 and PGE2 comparable to that found in normal host M phi supernatants caused approximately 38% inhibition whereas whole M phi supernatants decreased MLR reactivity by greater than 70%, suggesting that another factor(s) was necessary to account for the additional M phi-mediated suppression of lymphocyte function. Isoelectric focusing was used to fractionate normal host M phi supernatant. Two factors with isoelectric points in the pH ranges 7.0-8.5 and 4.5-5.0 were inhibitory in the MLR. An enhancing factor was also identified with an pI in the range of pH 6.0-7.0. These data suggest that TBH M phi-derived PGE production was increased over its normal counterpart, but that TBH T cells were less susceptible to its effect and an additional factor(s) was working in concert with PGE.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230157     DOI: 10.1016/0008-8749(84)90071-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells.

Authors:  A D Yurochko; P S Nagarkatti; M Nagarkatti; K D Elgert
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  T cell recruitment from the thymus to the spleen in tumor-bearing mice. I. Analysis of recruited cells by surface markers.

Authors:  K Tanaka; Y Koga; K Taniguchi; K Kamikaseda; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Splenocytes from tumor-bearing Corynebacterium parvum treated mice maintain interleukin-2 and -3 activity.

Authors:  A M Roberson; K D Elgert
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells.

Authors:  G M Lauro; N Di Lorenzo; M Grossi; A Maleci; B Guidetti
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.